Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Non-Current Assets (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Non-Current Assets for 8 consecutive years, with $32.3 million as the latest value for Q3 2024.

  • Quarterly Non-Current Assets fell 11.13% to $32.3 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $32.3 million through Sep 2024, down 78.9% year-over-year, with the annual reading at $35.2 million for FY2023, 13.32% down from the prior year.
  • Non-Current Assets hit $32.3 million in Q3 2024 for Solid Biosciences, down from $33.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $40.6 million in Q4 2022 to a low of $8.9 million in Q1 2022.
  • Historically, Non-Current Assets has averaged $24.8 million across 5 years, with a median of $32.3 million in 2024.
  • Biggest five-year swings in Non-Current Assets: crashed 31.59% in 2021 and later skyrocketed 335.67% in 2023.
  • Year by year, Non-Current Assets stood at $12.3 million in 2020, then fell by 20.38% to $9.8 million in 2021, then surged by 315.79% to $40.6 million in 2022, then decreased by 13.32% to $35.2 million in 2023, then decreased by 8.16% to $32.3 million in 2024.
  • Business Quant data shows Non-Current Assets for SLDB at $32.3 million in Q3 2024, $33.4 million in Q2 2024, and $34.5 million in Q1 2024.